Optimum Patient's Selection for Atrial Fibrillation Ablation Using Echocardiography

Area of Science:

• Cardiology
• Medical Technology

Background:

• Catheter ablation (CA) is a recommended treatment for symptomatic atrial fibrillation (AF).
• AF recurrence after CA affects 30-35% of patients, influenced by diverse clinical, genetic, and lifestyle factors.
• Optimizing patient selection is crucial to minimize AF recurrence post-CA.

Purpose of the Study:

• To review echocardiographic parameters, including myocardial deformation, for predicting AF recurrence after CA.
• To examine emerging clinical and biochemical predictors for comprehensive patient selection strategies.

Main Methods:

• Review of current literature on predictors of AF recurrence post-CA.
• Analysis of traditional and novel echocardiographic parameters (e.g., left atrial size, LV function, myocardial deformation via speckle tracking).
• Evaluation of emerging clinical factors (e.g., sleep apnea, renal failure) and novel biomarkers (e.g., MR-proANP, caspase-8).

Main Results:

• Echocardiographic parameters like left atrial size and LV function are known predictors, but no single factor is definitive.
• Myocardial deformation analysis shows promise in predicting AF recurrence.
• Emerging factors like obstructive sleep apnea and novel biomarkers may enhance risk prediction.

Conclusions:

• A multifactorial approach combining traditional and novel predictors is essential for accurate AF recurrence risk stratification post-CA.
• Further research into myocardial deformation and novel biomarkers can refine patient selection for CA.